TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BHVN

Biohaven Ltd.

Healthcare · Biotechnology

13.20$ -3.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BHVN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
93.0% 93.9% 95.4% 80.5% 66.7% 88.7% 86.2% 87.5% 81.6%
89.5% 91.1% 92.0% 74.0% 53.5% 31.0% 48.4% 16.1% 50.9%
89.5% 91.1% 92.0% 74.0% 53.5% 70.3% 74.4% 79.0% 70.7%
– – – 107.7% 7.0% 7.0% 2.6% 0.4% –
– – – 35.5% 4.7% 8.5% -0.1% – –
– – – 12.2% 10.3% 7.9% – – –
– – – 0.0% 1.0% 0.2% 0.3% 0.2% 0.3%
– – – 35.1% 13.0% 2.8% 3.6% 3.0% 4.1%
10.2% 48.0% 102.2% 31.1% 33.3% 18.6% 16.6% 31.2% 88.5%
6.4% 6.7% 19.2% 26.8% 29.5% 13.6% 10.8% 25.1% 25.7%
– – – 0.6% 0.3% 0.5% 0.6% 0.6% 1.3%
3.2% 3.7% 4.1% 2.5% 3.4% 1.6% 3.0% 2.9% 2.6%
– – – – 441.2% – – – 52.9%
89.8% 52.0% -2.2% 68.9% 66.7% 81.4% 83.4% 68.8% 11.5%
-138.0% -152.9% -282.4% -1,559.8% -1,820.2% -13.8% -97.3% -218.8% -461.7%
24.6% 16.7% 14.1% 35.3% 27.7% 6.8% 13.9% 14.8% 23.8%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?